By the age of 3, 83 percent of the nation's children have had at least one ear infection that turns a precious little one into a nonstop squaller.
Now University of Rochester Medical Center researchers are working on development of a vaccine that could wipe out childhood ear and sinus infections, as well as many cases of adult bronchitis.
Allergies that blight the lives of millions could be wiped out with a vaccine that wards off asthma, eczema and hay fever.
In only four years, a 'one size fits all' jab could be on the shelves.
Muriel Simmons, chief executive of the charity Allergy UK, said: "This has the power to transform people's lives."
When combined with an immune-boosting substance called an adjuvant, low doses of an experimental vaccine against a strain of avian influenza (H9N2) provoked a strong antibody response in human volunteers, report scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
CHONBURI, Thailand -- Inside a ramshackle Buddhist temple here on the country's southeastern coast, curious villagers gathered last fall as part of the United States' biggest gamble yet on stopping the AIDS pandemic.
The informational meeting was almost like a game show as attractive young hosts revved up the crowd, working up to the big question, boomed out over loudspeakers: Would the audience be willing to volunteer to test an experimental HIV vaccine?
With concerns as great as ever about a possible bird-flu pandemic, Chinese researchers have developed an avian-influenza vaccine that can be produced in much larger quantities than other trial vaccines so far.
A group of Chinese researchers published a study today in the British medical journal "The Lancet" describing their success in producing a vaccine for the H5N1 strain of the virus that is effective in low doses.
